US Patent Issued to The University of Hong Kong on March 31 for "Mesenchymal stromal cells as a reprogramming source for iPSC induction" (Chinese, American Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,295, issued on March 31, was assigned to The University of Hong Kong (Hong Kong).

"Mesenchymal stromal cells as a reprogramming source for iPSC induction" was invented by Chi-Fung Chan (Hong Kong), Kenneth Richard Boheler (Odenton, Md.), Jiangang Shen (Hong Kong), Ruixia Deng (Hong Kong) and Hing Yee Law (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are mesenchymal stromal cells as a reprogramming source for ipsc induction. In particular, Provided is a method for generating induced mesenchymal stromal cells (iMSCs), the iMSC generated by the method as well as the use thereof."

The patent was filed on Nov. 27, 2020, under Appli...